BioTrinity 2018

London, UK

Sunday, 22 Apr '18

BioTrinity offers unique access to investors, big pharma executives and innovative CEO's of emerging R&D companies seeking to strike deals and grow their networks.

The theme for BioTrinity 2018 is 'Next Generation Healthcare' which will explore via a range of insightful keynote and panel discussions including 'AI and Drug Discovery', 'An insight into Nanotechnology', 'Next Generation Chemistry' and 'The Evolution of the Life Science Investment Industry'.

Dr George Buckley and Dr Bodo Spori from the Domainex Business Development team will be there and look forward to meeting with you.  Request a 1-2-1 meeting to discuss your drug discovery programme.